Irinotecan HCl
Overview | |
Catalog # | bs-82413c-50-mg |
Product Name | Irinotecan HCl |
Specifications | |
Storage Buffer | Waxy lyophilized solid |
Storage Condition | -20°C |
Target | |
Product Information | Irinotecan is a semi-synthetic derivative of camptothecin that is an FDA approved anticancer drug. It is a prodrug that is converted by tissue esterases to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I.1,2 Although irinotecan is also a topoisomerase inhibitor, SN-38 is approximately 1000 times as potent in purified enzyme studies. In vitro cytotoxicity assays show much greater variability in potency between the two (2-2000 fold).3 |
Description | CAS Number: 136572-09-3 Chemical Name: (S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]-indolizino[1,2-b]quinolin-9-yl-[1,4’-bipiperidine]-1’-carboxylate hydrochloride Molecular weight: 586.69 ∙ 36.46 ∙ 54.05 Formula: C33H38N4O6 ∙ HCl ∙ 3H20 Solubility: DMSO (50 mg/ml) Ethanol (4 mg/ml) Water (4 mg/ml) Physical Properties: Yellow solid Purity: 98% by TLC, NMR (Conforms) |